Summary: Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company that is developing compounds that activate Tie2
Summary: Absci, a synthetic biology company whose platform technology aids in the drug discovery process,
Summary: AbSci has filed to raise $200 million in a U.S. IPO. The firm is
Summary: XELA is heavily indebted, with $1.5 billion maturing in the next 24 months. Most
Summary: Affimed recently reported their Q1 earnings that revealed a solid beat on EPS and
Summary: The company’s flagship project has reserves of 11.9 million ounces of gold and 478.5